Covance Inc (CVD) 106.42 $CVD Kitov Creates Pil
Post# of 273247
Posted On: 09/07/2016 9:06:05 AM
Covance Inc (CVD) 106.42 $CVD
Kitov Creates Pill for Safely Treating Osteoarthritis Pain and Hypertension
ACCESSWIRE - Tue May 03, 9:50AM CDT
NEW YORK, NY / ACCESSWIRE / May 3, 2016 / Combining two existing generic drugs, a new, safer solution to osteoarthritis pain is found; Kitov's drug passed Phase III with stunning results;
JNJ: 119.99 (+0.24), PFE: 34.76 (-0.01), LLY: 78.51 (unch), KTOV: 2.96 (+0.09), OA: 77.28 (-0.60), CVD: 106.42 (-0.71)
Global Rat Model Market Worth USD 602.3 Million by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: Biomedical Research Models Inc, Genoway S.A. & Sage Laboratories
M2 - Mon Feb 01, 3:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/xd2gpw/rat_model_market) has announced the addition of the "Rat Model Market by Type, Technology, Application, Service & Care Products - Forecasts to 2020" report to their offering. This comprehensive report predicts that the global rat model market will reach a value of USD 602.3 Million by 2020, growing with a CAGR of 9.4% from 2015 to 2020. The market for rat model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue). The breeding services market held the largest share of the services market in 2014 and is expected to grow at the highest CAGR during the forecast period. Key Topics Covered: Rat Model Market, by Type: - Inbred - Outbred - Conditioned/Surgically Modified - Hybrid/Congenic - Knockout - Immunodeficient Rat Model Market, by Technology: - Microinjection - Embryonic Stem Cell Injection - Nuclear Transferase Technology - Others Rat Model Market, by Application: - Toxicology - Oncology - Immunology & Inflammation - Central Nervous System - Diabetes - Others Rat Model Market, by Service: - Breeding - Cryopreservation - Quarantine - Rederivation - Genetic Testing - Model In-licensing - Other Services (Surgical and Line Rescue) Rat Model Market, by Region: - North America - U.S., Canada - Europe - Germany, U.K., France, Russia, Rest of Europe - Asia-Pacific - China, Japan, India, Rest of Asia-Pacific, RoW Rat Care Products Market, by Segment: - Bedding - Feed - Cages - Others Companies Mentioned: - Biomedical Research Models, Inc. - Charles River Laboratories, Inc. - Covance, Inc. - Genoway S.A. - Harlan Laboratories, Inc. - Janvier Labs - Sage Labs - Taconic Biosciences, Inc. - Transposagen Biopharmaceuticals, Inc. - Transviragen, Inc. Report Structure: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Dynamics 5 Market Share Analysis, By Key Players 6 Market Size 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles For more information visit http://www.researchandmarkets.com/research/xd...del_market
CVD: 106.42 (-0.71)
Dr. Nigel Brown to Serve as Senior Adviser to MedAvante
PR Newswire - Tue Dec 08, 8:36AM CST
MedAvante, Inc., a leading global provider of science-driven, technology-enabled signal detection solutions for clinical trials of treatments for central nervous system (CNS) disorders announced that Dr. Nigel Brown, former Corporate Vice President of Business Development and Strategy at Covance Inc., will serve as a senior adviser to the company.
CVD: 106.42 (-0.71)
Global Food Safety Testing Market - Analysis, Trends, Technologies & Forecast 2015-2020
M2 - Mon Dec 07, 5:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/jvgd62/food_safety) has announced the addition of the "Food Safety Testing Market: by Test; By Technique (PCR,Mass Spectrometry,Chromatography,Immunoassay,NMR),By Food (Meat & Poultry,Dairy Products,Fruits & Vegetables) - Forecast (2015 - 2020)" report to their offering. The global food safety testing market represents the overall testing services provided by contract laboratories and this market has been further segmented with respect to pathogens, food types and testing technologies. The market size and growth forecasts are with respect to the contract laboratory testing services provided by companies like SGS Group, Bureau Vertias, Eurofins and so on. The testing laboratories, analytical instruments manufacturers, food manufacturers and distributors are the key players in the overall value chain of this market. Various test types such as microbiology analysis, allergen analysis, toxin analysis, nutritional labeling, adulteration and GMO testing are conducted. Microbiology is the dominant etst type conducted to screen for various pathogen and non-pathogenic contamination. A detailed account of various pathogen testing is incorporated in the report. Among the various technologies used for testing PCR and Chromatography were the prominent types. The food products that are dominantly monitored regularly in the food testing market include Dairy Products and Meat & Poultry Industry. Americas dominated the market for food testing while Asia-Pacific is poised to exhibit the fastest growth. Companies are actively expanding their presence in emerging countries as government regulations are boosting demand for food safety testing services. Companies Mentioned: - Overseas Merchandise Inspection Co, Ltd (OMIC)-Omic USA Inc - TUV Rheinland Group - M?rieux Nutrisciences (Silliker, Inc) - Adpen Laboratories, Inc - ALS Limited( Campbell Brothers Limited) - Asurequality Limited - Genon Laboratories Ltd - COVANCE, INC - Elisa Technologies, Inc - Eurofin Scientific - SGS SA - Bureau Veritas SA - Intertek Group Plc Report Structure: 1. Global Food Safety Testing Market Overview 2. Executive Summary 3. Global Food Safety Testing Market Overview 4. Global Food Safety Testing Market Forces 5. Global Food Product Recalls Scenario 6. Food Safety Testing Market: Market Share Analysis 7. Global Food Safety Testing Market -By Testing Type 8. Global Food Safety Pathogen Testing Market by Geography and Food Type 9. Global Food Safety Testing Market - by Test Technique 10. Global Food Safety Testing Technologies Market - by Food Type 11. Global Food Safety Testing Technologies Market - by Region 12. Market Entropy 13. Company Profiles 15. Appendi For more information visit http://www.researchandmarkets.com/research/jv...ood_safety
CVD: 106.42 (-0.71)
Global Lyme Disease Diagnostic Devices (Echocardiogram, MRI, Electrocardiogram, Flow Cytometry) Market Analysis 2015-2020
M2 - Wed Sep 09, 5:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pw5dvs/lyme_disease) has announced the addition of the "Lyme Disease Diagnostic Devices Market Analysis (2015 -2020)By Diagnostic Tests (Serological, Lymphocytic Transformation, PCR Analysis, Immunofluorescence Staining); By Technologies (Echocardiogram, MRI, Electrocardiogram, Flow Cytometry)" report to their offering. Lyme disease caused by the spirochete Borrelia burgdorferi and transmitted by vector Ixodes scapular, is the most commonly reported vector-borne illness in the United States. Lyme disease incidence is increasing throughout the world. Lyme disease diagnostic devices market has been segmented by diagnostic tests, diagnostic technologies and end users. Each of these segmentations has been further classified into sub segments to give an in-depth and comprehensive analysis of the Lyme disease diagnostic devices market. Further the report provides geographic analysis of the Lyme disease and lists major companies involved in manufacturing of innovative diagnostic devices devices for the treatment of Lyme disease. Key Topics Covered: 1. Lyme Disease diagnostic devices- Market Overview 2. Executive Summary 3. Lyme Disease diagnostic devices - Market Landscape 4. Lyme Disease diagnostic devices - Market Forces 5. Lyme Disease diagnostic devices - Strategic Analysis 6. Lyme Disease diagnostic devices market - By Diagnostic Tests 7. Lyme Disease diagnostic devices market- By Diagnostic Technologies 8. Lyme Disease diagnostic devices market - By End Users 9. Lyme Disease diagnostic devices market- By Geographic Analysis 10. Company Profiles - Abbott Laboratories - Canon U.SLife Sciences - T2 Biosystems - Bio-Rad Laboratories - Alere Inc (ALR) - Roche Diagnostics International Ltd. - Graphene Frontiers - Covance Inc. - Boulder Diagnostics - Immunetics Inc. - GlaxoSmithKline Pharmaceuticals Ltd. - Affymetrix Inc. - Siemens AG - Baxter International Inc. - Fresenius Medical Care AG & Co. For more information visit http://www.researchandmarkets.com/research/pw...me_disease
ABT: 42.16 (+0.07), BAX: 46.07 (+0.12), ALR: 40.07 (+0.94), AFFX: 14.01 (+0.02), CVD: 106.42 (-0.71)
Analyzing the Global Biotechnology Industry 2015 - The Medical/Healthcare Segment is the Leading Segment of the Biotechnology Industry Consisting of nearly 60%
M2 - Tue Aug 18, 2:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r6ddnn/analyzing_the) has announced the addition of the "Analyzing the Global Biotechnology Industry 2015" report to their offering. Biotechnology as an industry has been around for many years now. The manipulation of biological processes is nothing new as the fermenting of grains and fruits to create alcoholic beverages to the discovery of penicillin has been around since the 1920s. Advances in genomics, molecular biology and computing power has made it possible for the field of biotechnology to advance and develop more targeted medicines, manufacture high nutrition crops, and even manufacture grow artificial organs and tissues. Emerging markets like China, Brazil and India are leading the sales in the global biotechnology market. The Americas and Europe regions hold the biggest share in the global biotechnology industry - Americas had a share of nearly 45%, followed by Europe accounting for nearly 30% of the global biotechnology industry. The medical/healthcare segment is the leading segment of the biotechnology industry and in 2014 it consisted of nearly 60% of the global biotech industry's total value. This was followed by the food and agriculture segment. The research analyzes the Global Biotechnology Industry in this comprehensive research report. Analyzing the Global Biotechnology Industry covers the biotech market from the year 2010 till 2019. The report analyzes a total of 23 biotech markets and over 40 biotech companies. Key Topics Covered: A. Executive Summary B. Industry Definition C. Global Biotechnology Industry D. Global Biotechnology Industry: Porter's Five Forces Framework Analysis E. Blurring Differences between Biotech & Pharma Companies F. Global Biotechnology Industry: Market Trends & Challenges G. Global Biotechnology Industry: Analysis of Key Markets H. Global Biotechnology Industry: Major Players Companies Mentioned - AbbVie Inc. - Abbott Laboratories - Acorda Therapeutics Inc. - Actelion Ltd - Amgen, Inc. - Amylin Pharmaceuticals, Inc. - Astellas Pharma Inc. - AstraZeneca Plc - Baxter International Inc. - Biocon Limited - Biogen Inc. - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - CSL Limited - Celgene Corporation - Covance Inc. - Crucell N.V. - Cubist Pharmaceuticals - Daiichi Sankyo Co., Ltd. - Esteve Group - F. Hoffmann-La Roche AG - GE Healthcare - Gentium S.p.A. - Genzyme Corporation - Gilead Sciences, Inc. - Grifols SA - ImmunoGen, Inc. - Johnson & Johnson - Menarini Group - Merck & Co., Inc. - Mitsubishi Tanabe Pharma Corporation - MorphoSys AG - Novartis AG For more information visit http://www.researchandmarkets.com/research/r6...lyzing_the
ACOR: 24.45 (+0.18), CVD: 106.42 (-0.71), JNJ: 119.99 (+0.24), ABBV: 64.62 (+0.01), ABT: 42.16 (+0.07), CBSTZ: 0.06 (unch), IMGN: 2.86 (+0.11), AMGN: 170.10 (-0.74), BMY: 57.00 (+0.04), GRFS: 16.05 (+0.01), GILD: 78.00 (+0.12), BAX: 46.07 (+0.12), AZN: 33.06 (-0.03), MRK: 63.45 (+0.21), NVS: 80.22 (+0.07), CELGZ: 1.25 (+0.07)
Global Ingredient Authentication Testing Market 2014-2020 - By Ingredient source, By Technology & By Geography
M2 - Wed Aug 12, 3:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dpf553/ingredient) has announced the addition of the "Ingredient Authentication Testing Market Analysis and Forecast (2014-2020): By Ingredient source (Plant, Animal, Bacteria and Fungi), By Technology (PCR, Chromatography, Spectroscopy and others) & By Geography" report to their offering. Ingredient Authentication broadly comprises of identity testing of ingredients as claimed by manufacturers. It essentially involves testing whether the ingredients that the manufacturer claims are actually there in the food product. Government regulations often require the natural products to be tested for product integrity and authentication of ingredients for nutritional content, to repeatedly check for adulterations. The National Centre for Complementary and Alternative Medicine (NCCAM) often requires many botanical and herbal products to be tested for Placebo Effect, while regular government authorities like FDA check for allopathic drugs and functional foods. These regulations are key drivers for repeated testing procedures and hence, will drive the demand for the Ingredient Authentication Testing market. Ingredient Authentication testing laboratories and in-house laboratories at the food or ingredient manufacturing facilities are the main places where the ingredient authentication testing is done. Key Topics Covered: 1. Global Ingredient Authentication Testing Market Overview 2. Executive Summary 3. Global Ingredient Authentication Testing Market Landscape 4. Global Ingredient Authentication Testing Market Forces 5. Global Ingredient Authentication Testing Market 6. Global Ingredient Authentication Testing Market - By Source of Origin 7. Global Ingredient Authentication Testing Market - By Technology 8. Global Ingredient Authentication Testing Market - By Geography 9. Market Entropy 10. Investment Opportunities - Analysis of Target companies/customers, Capital Investments, RoI, Payback Period & Source of Funds. 11. Company Profiles Companies Mentioned - Agilent Technologies, Inc. - Qiagen N.V. - Authen Technologies - T?V Rheinland Group - Thermo Fisher Scientific Inc. - Bureau Veritas S.A. - Eurofins Central Analytical Laboratories - Accugen Laboratories, Inc. - Adpen Laboratories Inc. - Vanguard Sciences - Genon Laboratories Ltd - Bio-Rad Laboratories, Inc. - IDEXX Laboratories Inc. - Overseas Merchandise Inspection Co., Ltd. - Merieux Nutrisciences Corporation - AB SCIEX - ELISA Technologies, Inc. - Bruker Corporation - SGS SA - Covance Inc. For more information visit http://www.researchandmarkets.com/research/dpf553/ingredient
A: 46.95 (-0.05), QGEN: 26.96 (+0.33), IDXX: 113.95 (-0.14), CVD: 106.42 (-0.71)
Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
PR Newswire - Mon Jul 13, 4:09PM CDT
Intensifying regulatory expectations, tougher inspection system, and instant need for patient reporting boost the adoption rate of pharmacovigilance among pharmaceutical companies. Rise in the prevalence of acute and chronic diseases has consequently led to an increase in the incidences of drug consumption, thus leading to growth in the number of adverse drug events and drug toxicity cases. Furthermore, safety regulations, risk of high-profile safety issues, large volume of post-market events to be reviewed along with negative media coverage have bound the pharmaceutical players to take support of various outsourcing services for drug monitoring. Two major outsourcing providers preferred by pharmaceutical manufacturers for pharmacovigilance services are namely, traditional CROs (e.g. Covance, Inc., Quintiles Transnational, INC Research, etc.) and BPOs (e.g. Capgemini, Cognizant, Infosys Ltd., Tata Consultancy Services Limited, etc.). Outsourcing services do not only help in cost saving, but also support process efficiency. Pharmaceutical companies are now entering into long-term partnerships/service agreements with CROs and BPOs to reduce the pharmacovigilance process related expenditure, incurred right from drug discovery to post-marketing approvals. In addition, pharmacovigilance requires skilled resources with excellent language skills and strong knowledge pertaining to case reporting due to which pharmaceutical companies are opting for outsourced pharmacovigilance services in order to reduce the burden of clerical functions as well as capital expenditures.
CVD: 106.42 (-0.71)
Alison A. Cornell to Join IFF as EVP & Chief Financial Officer
BusinessWire - Fri May 29, 6:04AM CDT
International Flavors & Fragrances Inc. (NYSE:IFF), a leading global creator of flavors and fragrances for consumer products, today announced that Alison A. Cornell will join its management team as Executive Vice President and Chief Financial Officer, effective July 8, 2015.
IFF: 138.77 (-0.22), CVD: 106.42 (-0.71)
Uptrend Call Working As Covance Stock Rises 32.9% (CVD)
Comtex SmarTrend(R) - Mon Apr 06, 10:09AM CDT
SmarTrend identified an Uptrend for Covance (NYSE:CVD) on October 22nd, 2014 at $80.09. In approximately 6 months, Covance has returned 32.88% as of today's recent price of $106.42.
CVD: 106.42 (-0.71)
32.9% Return Seen to Date on SmarTrend Covance Call (CVD)
Comtex SmarTrend(R) - Thu Mar 26, 4:54PM CDT
SmarTrend identified an Uptrend for Covance (NYSE:CVD) on October 22nd, 2014 at $80.09. In approximately 5 months, Covance has returned 32.88% as of today's recent price of $106.42.
CVD: 106.42 (-0.71)
Covance Shares Up 32.9% Since SmarTrend's Buy Recommendation (CVD)
Comtex SmarTrend(R) - Thu Mar 19, 11:24AM CDT
SmarTrend identified an Uptrend for Covance (NYSE:CVD) on October 22nd, 2014 at $80.09. In approximately 5 months, Covance has returned 32.88% as of today's recent price of $106.42.
CVD: 106.42 (-0.71)
Covance Has Returned 33.9% Since SmarTrend Recommendation (CVD)
Comtex SmarTrend(R) - Wed Feb 18, 11:03AM CST
SmarTrend identified an Uptrend for Covance (NYSE:CVD) on October 22nd, 2014 at $80.09. In approximately 4 months, Covance has returned 33.86% as of today's recent price of $107.20.
CVD: 106.42 (-0.71)
Covance Inc. Stockholders Approve Acquisition by Laboratory Corporation of America Holdings
PR Newswire - Wed Feb 18, 8:23AM CST
Covance Inc. (NYSE: CVD) (Covance) and Laboratory Corporation of America® Holdings (NYSE: LH) (LabCorp®) jointly announced that Covance's stockholders voted to adopt the previously announced merger agreement providing for the acquisition of Covance by LabCorp at the special meeting of Covance stockholders held earlier today. More than 99 percent of votes cast at the special meeting were in favor of the transaction, representing more than 78 percent of all outstanding Covance shares.
LH: 138.37 (+0.66), CVD: 106.42 (-0.71)
Kitov Creates Pill for Safely Treating Osteoarthritis Pain and Hypertension
ACCESSWIRE - Tue May 03, 9:50AM CDT
NEW YORK, NY / ACCESSWIRE / May 3, 2016 / Combining two existing generic drugs, a new, safer solution to osteoarthritis pain is found; Kitov's drug passed Phase III with stunning results;
JNJ: 119.99 (+0.24), PFE: 34.76 (-0.01), LLY: 78.51 (unch), KTOV: 2.96 (+0.09), OA: 77.28 (-0.60), CVD: 106.42 (-0.71)
Global Rat Model Market Worth USD 602.3 Million by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: Biomedical Research Models Inc, Genoway S.A. & Sage Laboratories
M2 - Mon Feb 01, 3:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/xd2gpw/rat_model_market) has announced the addition of the "Rat Model Market by Type, Technology, Application, Service & Care Products - Forecasts to 2020" report to their offering. This comprehensive report predicts that the global rat model market will reach a value of USD 602.3 Million by 2020, growing with a CAGR of 9.4% from 2015 to 2020. The market for rat model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue). The breeding services market held the largest share of the services market in 2014 and is expected to grow at the highest CAGR during the forecast period. Key Topics Covered: Rat Model Market, by Type: - Inbred - Outbred - Conditioned/Surgically Modified - Hybrid/Congenic - Knockout - Immunodeficient Rat Model Market, by Technology: - Microinjection - Embryonic Stem Cell Injection - Nuclear Transferase Technology - Others Rat Model Market, by Application: - Toxicology - Oncology - Immunology & Inflammation - Central Nervous System - Diabetes - Others Rat Model Market, by Service: - Breeding - Cryopreservation - Quarantine - Rederivation - Genetic Testing - Model In-licensing - Other Services (Surgical and Line Rescue) Rat Model Market, by Region: - North America - U.S., Canada - Europe - Germany, U.K., France, Russia, Rest of Europe - Asia-Pacific - China, Japan, India, Rest of Asia-Pacific, RoW Rat Care Products Market, by Segment: - Bedding - Feed - Cages - Others Companies Mentioned: - Biomedical Research Models, Inc. - Charles River Laboratories, Inc. - Covance, Inc. - Genoway S.A. - Harlan Laboratories, Inc. - Janvier Labs - Sage Labs - Taconic Biosciences, Inc. - Transposagen Biopharmaceuticals, Inc. - Transviragen, Inc. Report Structure: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Dynamics 5 Market Share Analysis, By Key Players 6 Market Size 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles For more information visit http://www.researchandmarkets.com/research/xd...del_market
CVD: 106.42 (-0.71)
Dr. Nigel Brown to Serve as Senior Adviser to MedAvante
PR Newswire - Tue Dec 08, 8:36AM CST
MedAvante, Inc., a leading global provider of science-driven, technology-enabled signal detection solutions for clinical trials of treatments for central nervous system (CNS) disorders announced that Dr. Nigel Brown, former Corporate Vice President of Business Development and Strategy at Covance Inc., will serve as a senior adviser to the company.
CVD: 106.42 (-0.71)
Global Food Safety Testing Market - Analysis, Trends, Technologies & Forecast 2015-2020
M2 - Mon Dec 07, 5:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/jvgd62/food_safety) has announced the addition of the "Food Safety Testing Market: by Test; By Technique (PCR,Mass Spectrometry,Chromatography,Immunoassay,NMR),By Food (Meat & Poultry,Dairy Products,Fruits & Vegetables) - Forecast (2015 - 2020)" report to their offering. The global food safety testing market represents the overall testing services provided by contract laboratories and this market has been further segmented with respect to pathogens, food types and testing technologies. The market size and growth forecasts are with respect to the contract laboratory testing services provided by companies like SGS Group, Bureau Vertias, Eurofins and so on. The testing laboratories, analytical instruments manufacturers, food manufacturers and distributors are the key players in the overall value chain of this market. Various test types such as microbiology analysis, allergen analysis, toxin analysis, nutritional labeling, adulteration and GMO testing are conducted. Microbiology is the dominant etst type conducted to screen for various pathogen and non-pathogenic contamination. A detailed account of various pathogen testing is incorporated in the report. Among the various technologies used for testing PCR and Chromatography were the prominent types. The food products that are dominantly monitored regularly in the food testing market include Dairy Products and Meat & Poultry Industry. Americas dominated the market for food testing while Asia-Pacific is poised to exhibit the fastest growth. Companies are actively expanding their presence in emerging countries as government regulations are boosting demand for food safety testing services. Companies Mentioned: - Overseas Merchandise Inspection Co, Ltd (OMIC)-Omic USA Inc - TUV Rheinland Group - M?rieux Nutrisciences (Silliker, Inc) - Adpen Laboratories, Inc - ALS Limited( Campbell Brothers Limited) - Asurequality Limited - Genon Laboratories Ltd - COVANCE, INC - Elisa Technologies, Inc - Eurofin Scientific - SGS SA - Bureau Veritas SA - Intertek Group Plc Report Structure: 1. Global Food Safety Testing Market Overview 2. Executive Summary 3. Global Food Safety Testing Market Overview 4. Global Food Safety Testing Market Forces 5. Global Food Product Recalls Scenario 6. Food Safety Testing Market: Market Share Analysis 7. Global Food Safety Testing Market -By Testing Type 8. Global Food Safety Pathogen Testing Market by Geography and Food Type 9. Global Food Safety Testing Market - by Test Technique 10. Global Food Safety Testing Technologies Market - by Food Type 11. Global Food Safety Testing Technologies Market - by Region 12. Market Entropy 13. Company Profiles 15. Appendi For more information visit http://www.researchandmarkets.com/research/jv...ood_safety
CVD: 106.42 (-0.71)
Global Lyme Disease Diagnostic Devices (Echocardiogram, MRI, Electrocardiogram, Flow Cytometry) Market Analysis 2015-2020
M2 - Wed Sep 09, 5:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pw5dvs/lyme_disease) has announced the addition of the "Lyme Disease Diagnostic Devices Market Analysis (2015 -2020)By Diagnostic Tests (Serological, Lymphocytic Transformation, PCR Analysis, Immunofluorescence Staining); By Technologies (Echocardiogram, MRI, Electrocardiogram, Flow Cytometry)" report to their offering. Lyme disease caused by the spirochete Borrelia burgdorferi and transmitted by vector Ixodes scapular, is the most commonly reported vector-borne illness in the United States. Lyme disease incidence is increasing throughout the world. Lyme disease diagnostic devices market has been segmented by diagnostic tests, diagnostic technologies and end users. Each of these segmentations has been further classified into sub segments to give an in-depth and comprehensive analysis of the Lyme disease diagnostic devices market. Further the report provides geographic analysis of the Lyme disease and lists major companies involved in manufacturing of innovative diagnostic devices devices for the treatment of Lyme disease. Key Topics Covered: 1. Lyme Disease diagnostic devices- Market Overview 2. Executive Summary 3. Lyme Disease diagnostic devices - Market Landscape 4. Lyme Disease diagnostic devices - Market Forces 5. Lyme Disease diagnostic devices - Strategic Analysis 6. Lyme Disease diagnostic devices market - By Diagnostic Tests 7. Lyme Disease diagnostic devices market- By Diagnostic Technologies 8. Lyme Disease diagnostic devices market - By End Users 9. Lyme Disease diagnostic devices market- By Geographic Analysis 10. Company Profiles - Abbott Laboratories - Canon U.SLife Sciences - T2 Biosystems - Bio-Rad Laboratories - Alere Inc (ALR) - Roche Diagnostics International Ltd. - Graphene Frontiers - Covance Inc. - Boulder Diagnostics - Immunetics Inc. - GlaxoSmithKline Pharmaceuticals Ltd. - Affymetrix Inc. - Siemens AG - Baxter International Inc. - Fresenius Medical Care AG & Co. For more information visit http://www.researchandmarkets.com/research/pw...me_disease
ABT: 42.16 (+0.07), BAX: 46.07 (+0.12), ALR: 40.07 (+0.94), AFFX: 14.01 (+0.02), CVD: 106.42 (-0.71)
Analyzing the Global Biotechnology Industry 2015 - The Medical/Healthcare Segment is the Leading Segment of the Biotechnology Industry Consisting of nearly 60%
M2 - Tue Aug 18, 2:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r6ddnn/analyzing_the) has announced the addition of the "Analyzing the Global Biotechnology Industry 2015" report to their offering. Biotechnology as an industry has been around for many years now. The manipulation of biological processes is nothing new as the fermenting of grains and fruits to create alcoholic beverages to the discovery of penicillin has been around since the 1920s. Advances in genomics, molecular biology and computing power has made it possible for the field of biotechnology to advance and develop more targeted medicines, manufacture high nutrition crops, and even manufacture grow artificial organs and tissues. Emerging markets like China, Brazil and India are leading the sales in the global biotechnology market. The Americas and Europe regions hold the biggest share in the global biotechnology industry - Americas had a share of nearly 45%, followed by Europe accounting for nearly 30% of the global biotechnology industry. The medical/healthcare segment is the leading segment of the biotechnology industry and in 2014 it consisted of nearly 60% of the global biotech industry's total value. This was followed by the food and agriculture segment. The research analyzes the Global Biotechnology Industry in this comprehensive research report. Analyzing the Global Biotechnology Industry covers the biotech market from the year 2010 till 2019. The report analyzes a total of 23 biotech markets and over 40 biotech companies. Key Topics Covered: A. Executive Summary B. Industry Definition C. Global Biotechnology Industry D. Global Biotechnology Industry: Porter's Five Forces Framework Analysis E. Blurring Differences between Biotech & Pharma Companies F. Global Biotechnology Industry: Market Trends & Challenges G. Global Biotechnology Industry: Analysis of Key Markets H. Global Biotechnology Industry: Major Players Companies Mentioned - AbbVie Inc. - Abbott Laboratories - Acorda Therapeutics Inc. - Actelion Ltd - Amgen, Inc. - Amylin Pharmaceuticals, Inc. - Astellas Pharma Inc. - AstraZeneca Plc - Baxter International Inc. - Biocon Limited - Biogen Inc. - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - CSL Limited - Celgene Corporation - Covance Inc. - Crucell N.V. - Cubist Pharmaceuticals - Daiichi Sankyo Co., Ltd. - Esteve Group - F. Hoffmann-La Roche AG - GE Healthcare - Gentium S.p.A. - Genzyme Corporation - Gilead Sciences, Inc. - Grifols SA - ImmunoGen, Inc. - Johnson & Johnson - Menarini Group - Merck & Co., Inc. - Mitsubishi Tanabe Pharma Corporation - MorphoSys AG - Novartis AG For more information visit http://www.researchandmarkets.com/research/r6...lyzing_the
ACOR: 24.45 (+0.18), CVD: 106.42 (-0.71), JNJ: 119.99 (+0.24), ABBV: 64.62 (+0.01), ABT: 42.16 (+0.07), CBSTZ: 0.06 (unch), IMGN: 2.86 (+0.11), AMGN: 170.10 (-0.74), BMY: 57.00 (+0.04), GRFS: 16.05 (+0.01), GILD: 78.00 (+0.12), BAX: 46.07 (+0.12), AZN: 33.06 (-0.03), MRK: 63.45 (+0.21), NVS: 80.22 (+0.07), CELGZ: 1.25 (+0.07)
Global Ingredient Authentication Testing Market 2014-2020 - By Ingredient source, By Technology & By Geography
M2 - Wed Aug 12, 3:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/dpf553/ingredient) has announced the addition of the "Ingredient Authentication Testing Market Analysis and Forecast (2014-2020): By Ingredient source (Plant, Animal, Bacteria and Fungi), By Technology (PCR, Chromatography, Spectroscopy and others) & By Geography" report to their offering. Ingredient Authentication broadly comprises of identity testing of ingredients as claimed by manufacturers. It essentially involves testing whether the ingredients that the manufacturer claims are actually there in the food product. Government regulations often require the natural products to be tested for product integrity and authentication of ingredients for nutritional content, to repeatedly check for adulterations. The National Centre for Complementary and Alternative Medicine (NCCAM) often requires many botanical and herbal products to be tested for Placebo Effect, while regular government authorities like FDA check for allopathic drugs and functional foods. These regulations are key drivers for repeated testing procedures and hence, will drive the demand for the Ingredient Authentication Testing market. Ingredient Authentication testing laboratories and in-house laboratories at the food or ingredient manufacturing facilities are the main places where the ingredient authentication testing is done. Key Topics Covered: 1. Global Ingredient Authentication Testing Market Overview 2. Executive Summary 3. Global Ingredient Authentication Testing Market Landscape 4. Global Ingredient Authentication Testing Market Forces 5. Global Ingredient Authentication Testing Market 6. Global Ingredient Authentication Testing Market - By Source of Origin 7. Global Ingredient Authentication Testing Market - By Technology 8. Global Ingredient Authentication Testing Market - By Geography 9. Market Entropy 10. Investment Opportunities - Analysis of Target companies/customers, Capital Investments, RoI, Payback Period & Source of Funds. 11. Company Profiles Companies Mentioned - Agilent Technologies, Inc. - Qiagen N.V. - Authen Technologies - T?V Rheinland Group - Thermo Fisher Scientific Inc. - Bureau Veritas S.A. - Eurofins Central Analytical Laboratories - Accugen Laboratories, Inc. - Adpen Laboratories Inc. - Vanguard Sciences - Genon Laboratories Ltd - Bio-Rad Laboratories, Inc. - IDEXX Laboratories Inc. - Overseas Merchandise Inspection Co., Ltd. - Merieux Nutrisciences Corporation - AB SCIEX - ELISA Technologies, Inc. - Bruker Corporation - SGS SA - Covance Inc. For more information visit http://www.researchandmarkets.com/research/dpf553/ingredient
A: 46.95 (-0.05), QGEN: 26.96 (+0.33), IDXX: 113.95 (-0.14), CVD: 106.42 (-0.71)
Pharmacovigilance Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
PR Newswire - Mon Jul 13, 4:09PM CDT
Intensifying regulatory expectations, tougher inspection system, and instant need for patient reporting boost the adoption rate of pharmacovigilance among pharmaceutical companies. Rise in the prevalence of acute and chronic diseases has consequently led to an increase in the incidences of drug consumption, thus leading to growth in the number of adverse drug events and drug toxicity cases. Furthermore, safety regulations, risk of high-profile safety issues, large volume of post-market events to be reviewed along with negative media coverage have bound the pharmaceutical players to take support of various outsourcing services for drug monitoring. Two major outsourcing providers preferred by pharmaceutical manufacturers for pharmacovigilance services are namely, traditional CROs (e.g. Covance, Inc., Quintiles Transnational, INC Research, etc.) and BPOs (e.g. Capgemini, Cognizant, Infosys Ltd., Tata Consultancy Services Limited, etc.). Outsourcing services do not only help in cost saving, but also support process efficiency. Pharmaceutical companies are now entering into long-term partnerships/service agreements with CROs and BPOs to reduce the pharmacovigilance process related expenditure, incurred right from drug discovery to post-marketing approvals. In addition, pharmacovigilance requires skilled resources with excellent language skills and strong knowledge pertaining to case reporting due to which pharmaceutical companies are opting for outsourced pharmacovigilance services in order to reduce the burden of clerical functions as well as capital expenditures.
CVD: 106.42 (-0.71)
Alison A. Cornell to Join IFF as EVP & Chief Financial Officer
BusinessWire - Fri May 29, 6:04AM CDT
International Flavors & Fragrances Inc. (NYSE:IFF), a leading global creator of flavors and fragrances for consumer products, today announced that Alison A. Cornell will join its management team as Executive Vice President and Chief Financial Officer, effective July 8, 2015.
IFF: 138.77 (-0.22), CVD: 106.42 (-0.71)
Uptrend Call Working As Covance Stock Rises 32.9% (CVD)
Comtex SmarTrend(R) - Mon Apr 06, 10:09AM CDT
SmarTrend identified an Uptrend for Covance (NYSE:CVD) on October 22nd, 2014 at $80.09. In approximately 6 months, Covance has returned 32.88% as of today's recent price of $106.42.
CVD: 106.42 (-0.71)
32.9% Return Seen to Date on SmarTrend Covance Call (CVD)
Comtex SmarTrend(R) - Thu Mar 26, 4:54PM CDT
SmarTrend identified an Uptrend for Covance (NYSE:CVD) on October 22nd, 2014 at $80.09. In approximately 5 months, Covance has returned 32.88% as of today's recent price of $106.42.
CVD: 106.42 (-0.71)
Covance Shares Up 32.9% Since SmarTrend's Buy Recommendation (CVD)
Comtex SmarTrend(R) - Thu Mar 19, 11:24AM CDT
SmarTrend identified an Uptrend for Covance (NYSE:CVD) on October 22nd, 2014 at $80.09. In approximately 5 months, Covance has returned 32.88% as of today's recent price of $106.42.
CVD: 106.42 (-0.71)
Covance Has Returned 33.9% Since SmarTrend Recommendation (CVD)
Comtex SmarTrend(R) - Wed Feb 18, 11:03AM CST
SmarTrend identified an Uptrend for Covance (NYSE:CVD) on October 22nd, 2014 at $80.09. In approximately 4 months, Covance has returned 33.86% as of today's recent price of $107.20.
CVD: 106.42 (-0.71)
Covance Inc. Stockholders Approve Acquisition by Laboratory Corporation of America Holdings
PR Newswire - Wed Feb 18, 8:23AM CST
Covance Inc. (NYSE: CVD) (Covance) and Laboratory Corporation of America® Holdings (NYSE: LH) (LabCorp®) jointly announced that Covance's stockholders voted to adopt the previously announced merger agreement providing for the acquisition of Covance by LabCorp at the special meeting of Covance stockholders held earlier today. More than 99 percent of votes cast at the special meeting were in favor of the transaction, representing more than 78 percent of all outstanding Covance shares.
LH: 138.37 (+0.66), CVD: 106.42 (-0.71)
(0)
(0)Scroll down for more posts ▼